Future of Global Extracorporeal Membrane Oxygenation Machine Market

According to a new report by Grand View Research, Inc., the global extracorporeal membrane oxygenation (ECMO) machine market is projected to reach a market size of USD 445.7 million by the year 2030. This anticipated growth reflects a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2024 to 2030. The steady expansion of this market can be primarily attributed to several key factors, including the increasing global prevalence of cardiopulmonary and respiratory diseases, the rising adoption of ECMO machines across healthcare institutions such as hospitals and critical care units, and ongoing technological innovations that continue to improve the functionality and effectiveness of these life-support systems. As demand grows for advanced technologies capable of supporting or replacing cardiac and pulmonary function in critically ill patients, ECMO machines are gaining traction as essential tools in intensive care settings.

The global burden of cardiovascular and respiratory diseases continues to rise significantly. Conditions such as coronary artery disease, cerebrovascular disease, rheumatic and congenital heart disorders, and serious respiratory conditions—including acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD)—remain among the leading causes of mortality worldwide. For example, the World Heart Federation reports that cardiovascular diseases account for approximately 18.6 million deaths each year. Similarly, ARDS alone affects around 190,000 individuals annually in the United States. These alarming statistics highlight the growing need for critical life-support interventions, thereby accelerating the demand for ECMO machines that can provide temporary support for patients experiencing severe cardiac or respiratory failure.

Further supporting market growth is the rapid pace of technological advancement in ECMO systems. The development of more compact and portable components has significantly improved the practicality and usability of these machines in various clinical settings. For instance, the miniaturization of machine parts—such as hollow fiber pumps and oxygenators—has made it easier to transport and manage critically ill patients, even during inter-facility transfers. Additionally, recent innovations in system design, including advanced rotary pumps, dual-lumen cannulas, and high-efficiency oxygenators, have enhanced the performance and safety of ECMO therapy. New techniques for cannulation are also contributing to broader adoption by making the machines easier and safer to use.

A notable example of such innovation is the launch of the "Liby" System by Inspira Technologies OXY B.H.N. Ltd. in 2022. This advanced life support platform is designed for the treatment of patients suffering from severe heart and lung failure. The introduction of technologically sophisticated products like the Liby System demonstrates the ongoing evolution of ECMO technology and its growing role in modern healthcare. Similar product launches and advancements are expected to further propel market expansion in the years to come, as healthcare providers seek more effective solutions to manage life-threatening cardiopulmonary conditions.

Curious about the Extracorporeal Membrane Oxygenation Machine Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

Here are some commonly asked questions related to the Extracorporeal Membrane Oxygenation Machine Market, along with answers that provide essential insights.

1. How big is the extracorporeal membrane oxygenation machine market?

The global extracorporeal membrane oxygenation machine market size was estimated at USD 307.9 million in 2023 and is expected to reach USD 322.9 million in 2024.

2. What is the extracorporeal membrane oxygenation machine market growth?

The global extracorporeal membrane oxygenation machine market is expected to grow at a compound annual growth rate of 5.5% from 2024 to 2030 to reach USD 445.7 million by 2030.

3. Which segment accounted for the largest ECMO machine market share?

North America dominated the ECMO machine market with a share of 39.5% in 2023. This is attributable to government support for quality healthcare, high purchasing power parity of patients, and increasing prevalence of diseases such as chronic obstructive pulmonary disease (COPD).

4. Who are the key players in the extracorporeal membrane oxygenation machine market?

Some key players operating in the ECMO machine market include Medtronic plc, Sorin Group, Terumo Cardiovascular Systems Corporation, MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Nipro Medical Corporation, and Microport Scientific Corporation.

5. What are the factors driving the extracorporeal membrane oxygenation machine market?

Key factors that are driving the extracorporeal membrane oxygenation machine market growth include the rising prevalence of cardiopulmonary and respiratory diseases, increasing adoption of ECMO machines in hospitals, technological advancement in ECMO machines, and growing awareness towards the application of ECMO.

Order a free sample PDF of the Extracorporeal Membrane Oxygenation Machine Market Intelligence Study, published by Grand View Research.